ARA-290 is a peptide derived from erythropoietin (EPO) researched for tissue repair and neuropathic pain applications without the blood-stimulating effects of EPO.
Selectively activates the innate repair receptor (IRR) for tissue-protective effects without erythropoietic activity.
Peptides studied for their potential in wound healing, tendon/ligament repair, gut healing, and general tissue regeneration.
This peptide is primarily sold as a research-only compound in lyophilized powder form. It is not approved for human use and is intended for laboratory research purposes only.
Tissue healing
Enhanced tissue repair
Tissue repair
Collagen production
Browse our verified directory of pharmacies, telehealth providers, and research vendors.
Browse ProvidersThe information provided about ARA-290 is for educational and research purposes only. This content is not intended as medical advice, diagnosis, or treatment recommendation.ARA-290 is a research compound and may not be approved for human use. Always consult with a qualified healthcare provider before considering any peptide therapy. The Peptide List does not sell peptides or provide medical services.
This website is for informational purposes only and does not constitute medical advice. Consult a licensed physician before using any peptides. Provider listings do not constitute endorsements. None of the statements on this site have been evaluated by the FDA.